Makoto Okabe
Direttore/Membro del Consiglio presso NORITAKE CO., LIMITED
Profilo
Makoto Okabe is currently a Director & Senior Managing Executive Officer at Noritake Co., Ltd.
since 2023.
Prior to this, Mr. Okabe was a Director at ImmunoFrontier, Inc.
Posizioni attive di Makoto Okabe
Società | Posizione | Inizio |
---|---|---|
NORITAKE CO., LIMITED | Direttore/Membro del Consiglio | 23/06/2023 |
Precedenti posizioni note di Makoto Okabe
Società | Posizione | Fine |
---|---|---|
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NORITAKE CO., LIMITED | Producer Manufacturing |
Aziende private | 1 |
---|---|
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Commercial Services |
- Borsa valori
- Insiders
- Makoto Okabe